Evidence map›Paper›PMID 36712338›Full record

ArticlePNAS nexus2022

Risk assessment for long- and short-range airborne transmission of SARS-CoV-2, indoors and outdoors.

Florian Poydenot, Ismael Abdourahamane, Elsa Caplain, Samuel Der, Jacques Haiech, Antoine Jallon, Inés Khoutami, Amir Loucif, Emil Marinov, Bruno Andreotti

Open access · goldAbstract read
In one paragraph

Article in PNAS nexus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Methodology of Epidemic Risk Analysis in the Naval Military.International journal of environmental research and public health · 2025
    Review
  4. Article
  5. On modelling airborne infection risk.Royal Society open science · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Estimation of air change rate by COEnvironmental and occupational health practice · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Florian PoydenotLaboratoire de Physique de l'Ecole Normale Supérieure (LPENS), CNRS UMR 8023, Ecole Normale Supérieure, Université PSL, Sorbonne Université, and Université Paris Cité, 24 rue Lhomond, 75005 Paris, France.ORCID https://orcid.org/0000-0002-9552-4055
Ismael AbdourahamaneLaboratoire de Physique de l'Ecole Normale Supérieure (LPENS), CNRS UMR 8023, Ecole Normale Supérieure, Université PSL, Sorbonne Université, and Université Paris Cité, 24 rue Lhomond, 75005 Paris, France.
Elsa CaplainLaboratoire de Physique de l'Ecole Normale Supérieure (LPENS), CNRS UMR 8023, Ecole Normale Supérieure, Université PSL, Sorbonne Université, and Université Paris Cité, 24 rue Lhomond, 75005 Paris, France.
Samuel DerLaboratoire de Physique de l'Ecole Normale Supérieure (LPENS), CNRS UMR 8023, Ecole Normale Supérieure, Université PSL, Sorbonne Université, and Université Paris Cité, 24 rue Lhomond, 75005 Paris, France.
Jacques HaiechCogitamus Laboratory and CNRS UMR 7242 BSC, 300 Bd Sébastien Brant, CS 10413, 67412 Illkirch Cedex, France.
Antoine JallonLaboratoire de Physique de l'Ecole Normale Supérieure (LPENS), CNRS UMR 8023, Ecole Normale Supérieure, Université PSL, Sorbonne Université, and Université Paris Cité, 24 rue Lhomond, 75005 Paris, France.
Inés KhoutamiLaboratoire de Physique de l'Ecole Normale Supérieure (LPENS), CNRS UMR 8023, Ecole Normale Supérieure, Université PSL, Sorbonne Université, and Université Paris Cité, 24 rue Lhomond, 75005 Paris, France.
Amir LoucifLaboratoire de Physique de l'Ecole Normale Supérieure (LPENS), CNRS UMR 8023, Ecole Normale Supérieure, Université PSL, Sorbonne Université, and Université Paris Cité, 24 rue Lhomond, 75005 Paris, France.
Emil MarinovLaboratoire de Physique de l'Ecole Normale Supérieure (LPENS), CNRS UMR 8023, Ecole Normale Supérieure, Université PSL, Sorbonne Université, and Université Paris Cité, 24 rue Lhomond, 75005 Paris, France.
Bruno AndreottiLaboratoire de Physique de l'Ecole Normale Supérieure (LPENS), CNRS UMR 8023, Ecole Normale Supérieure, Université PSL, Sorbonne Université, and Université Paris Cité, 24 rue Lhomond, 75005 Paris, France.ORCID https://orcid.org/0000-0001-8328-6232
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preventive measures to reduce infection are needed to combat the COVID-19 pandemic and prepare for a possible endemic phase. Current prophylactic vaccines are highly effective to prevent disease but lose their ability to reduce viral transmission as viral evolution leads to increasing immune escape. Long-term proactive public health policies must therefore complement vaccination with available nonpharmaceutical interventions aiming to reduce the viral transmission risk in public spaces. Here, we revisit the quantitative assessment of airborne transmission risk, considering asymptotic limits that considerably simplify its expression. We show that the aerosol transmission risk is the product of three factors: a biological factor that depends on the viral strain, a hydrodynamical factor defined as the ratio of concentration in viral particles between inhaled and exhaled air, and a face mask filtering factor. The short-range contribution to the risk, present both indoors and outdoors, is related to the turbulent dispersion of exhaled aerosols by air drafts and by convection (indoors), or by the wind (outdoors). We show experimentally that airborne droplets and CO

Indexed as

carbon dioxideCOVID-19infection riskSARS-CoV-2

Identifiers

PMID36712338
PMCPMC9802175
OpenAlexW4302763571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.